Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Impurity
Testosterone Impurity 23 is a known impurity associated with Testosterone. This compound can be utilized in the analysis and quality control of Testosterone formulations, helping to ensure the purity and efficacy of pharmaceutical products. Its presence may affect the biological activity of the primary compound, making it relevant for studies focused on pharmacokinetics and toxicology. -
Drug Impurity
Atorvastatin impurity 1 is a characterized impurity associated with Atorvastatin, a widely used statin for cholesterol management. This compound can be utilized for analytical purposes in the quality control of atorvastatin formulations, ensuring the purity and safety of pharmaceutical products. Its presence is critical for understanding the metabolic pathways and pharmacological effects of atorvastatin in various research applications. -
Drug Impurity
Bupropion impurity 5 is a chemical impurity associated with Bupropion, primarily identified during the synthesis and analytical evaluation of the drug. This impurity serves as an important reference standard for quality control and analytical studies in pharmaceutical research. Its characterization aids in ensuring compliance with regulatory standards and contributes to the understanding of the purity and stability profiles of Bupropion formulations. -
Drug Impurity
Levofloxacin impurity 13 is identified as a drug impurity associated with the antibiotic Levofloxacin. It provides crucial insights for impurity profiling, method validation, and quality control in pharmaceutical research. Its analysis is essential for ensuring the purity and safety of final drug formulations and complies with regulatory standards in drug development. -
Drug Impurity
Trazodone impurity 7 dihydrochloride is a chemical impurity associated with Trazodone dihydrochloride. It serves as a reference standard for identifying and quantifying impurities in pharmaceutical formulations. This compound is relevant in the evaluation of drug purity and stability during research and quality control processes in the development of Trazodone-related therapies. -
Drug Impurity
Methotrexate impurity 3 is a known impurity of the chemotherapeutic agent Methotrexate. This compound serves as a reference standard in analytical chemistry and plays a critical role in the assessment of drug purity and quality control. Its characterization is vital for evaluating the safety and efficacy of Methotrexate formulations in various pharmaceutical applications. -
Drug Impurity
Lenvatinib impurity 1 is a chemical impurity associated with the drug Lenvatinib, which targets receptor tyrosine kinases involved in tumor proliferation and angiogenesis. This impurity is relevant for quality control and analytical assessments in pharmaceutical research, ensuring the integrity of Lenvatinib formulations. It can be utilized in stability studies and the development of analytical methods for drug characterization. -
Drug Impurity
Amodiaquine impurity 3 is a chemical impurity associated with the antimalarial drug amodiaquine. This compound plays a crucial role in the analysis of drug purity and stability, serving as a reference in quality control and regulatory compliance. Its detection and characterization are essential for assessing drug formulation integrity and ensuring patient safety in pharmacological research. -
Drug Impurity
Metoprolol impurity 4 is a drug impurity related to the beta-blocker Metoprolol, primarily acting as a marker for quality control in pharmaceutical formulations. This compound is essential for assessing the purity of Metoprolol during the manufacturing process, as impurities can affect the drug’s efficacy and safety. Its analysis is critical in compliance with regulatory standards and ensuring the therapeutic integrity of β-adrenergic antagonists. -
Drug Impurity
Estradiol impurity 9 (9,11-Didehydrooestriol) is a chemical impurity related to estradiol, predominantly studied in pharmacological contexts. It is significant for its potential impact on the analytical assessment of estradiol formulations and can influence drug development and quality control processes. Researchers may utilize this compound to better understand estradiol's stability, metabolic pathways, and the implications of impurities in hormone-based therapies. -
Drug Impurity
Fluocinolone impurity 1 is a known impurity of the corticosteroid Fluocinolone, which primarily targets glucocorticoid receptors. This compound serves as a reference standard for quality control in the synthesis and formulation of Fluocinolone, aiding in the assessment of purity and regulatory compliance. Its identification and analysis are crucial for ensuring the integrity of corticosteroid products used in therapeutic applications. -
Drug Impurity
Montelukast impurity 2 sodium is a chemical impurity related to Montelukast sodium. This compound is important for analytical and quality control purposes in pharmaceutical research. It serves as a reference standard to assess the purity of Montelukast sodium and can aid in the development and validation of analytical methods for drug formulation testing. -
Drug Impurity
Estradiol impurity 4 is a known impurity of estradiol, primarily associated with its synthesis and analysis. This compound is relevant in the context of pharmaceutical research for the evaluation of drug purity and quality. Its presence in estradiol formulations may impact the pharmacological profile, making it crucial for compliance with regulatory standards in drug development and quality control. -
Drug Impurity
Clobazam impurity 3 is a known impurity of the anxiolytic agent Clobazam. Its presence in pharmaceutical formulations may affect the quality and efficacy of the final product. Research applications include analytical testing, purity assessment, and stability studies of Clobazam and related compounds, providing essential insights into drug composition and safety. -
Drug Impurity
Tenofovir impurity 16 is a chemical impurity associated with the antiviral agent Tenofovir. This compound is essential for studies focused on the characterization and quantification of drug impurities. Its analysis is critical for ensuring the purity and safety of Tenofovir formulations in pharmaceutical research and development. -
Drug Impurity
Abacavir impurity 4 is a known impurity of the antiretroviral drug Abacavir. Its presence is significant in pharmaceutical research and development, as it may affect the purity and safety profiles of drug formulations. This compound is primarily utilized in analytical testing and quality control processes to ensure the compliance and integrity of Abacavir-related products. -
Drug Impurity
Rotigotine impurity 1 is a known impurity of the dopaminergic agent Rotigotine. This compound is primarily analyzed in the context of pharmacological research and quality control for drug formulations. Its presence and characterization are crucial for validating purity, understanding metabolic pathways, and ensuring the safety and efficacy of Rotigotine in clinical applications. -
Drug Impurity
Palbociclib impurity 1 is a known impurity of Palbociclib, a selective inhibitor of cyclin-dependent kinases 4 and 6 (CDK4/6). This compound serves as an analytical standard for the characterization and quantification of Palbociclib and its related substances in various research applications. Its presence can impact the purity profile and overall efficacy of therapeutic formulations, making it essential for quality control in pharmaceutical development. -
Drug Impurity
Prednisolone Impurity 2 is an impurity derived from Prednisolone. It serves as a critical reference standard for quality control and analytical testing in pharmaceutical research. Its assessment is essential for ensuring the purity and safety of Prednisolone formulations, thereby supporting compliance with regulatory standards in drug development and manufacturing. -
Drug Impurity
Fulvestrant impurity 5 is a recognized impurity of the selective estrogen receptor downregulator Fulvestrant. It serves as an important reference compound in the assessment of drug purity and the development of analytical methods in pharmaceutical research. This impurity can aid in the evaluation of Fulvestrant formulations and contribute to the understanding of its metabolic byproducts in pharmacokinetic studies. -
Drug Impurity
Quetiapine impurity 26 is a relevant impurity associated with quetiapine, an atypical antipsychotic. This compound is significant for both analytical and quality control applications in pharmaceutical research. It serves as a crucial standard for assessing the purity and ensuring the safety of quetiapine formulations, which is important in drug development and regulatory compliance. -
Drug Impurity
Lidocaine impurity 1 is a known impurity of Lidocaine, primarily serving as a reference standard in drug testing and quality control. This compound is utilized in pharmaceutical research to assess the purity of Lidocaine formulations and to ensure compliance with regulatory standards. Its presence can impact the efficacy and safety profiles of Lidocaine-based medications, making it crucial for analytical studies. -
Drug Impurity
Rosuvastatin impurity 19 is a known impurity associated with the cholesterol-lowering agent Rosuvastatin. Its presence can serve as a marker in the quality control processes of pharmaceutical formulations. This compound is essential for researchers and manufacturers focused on drug purity assessment, stability testing, and regulatory compliance in the development of statin-based therapies. -
Drug Impurity
Linagliptin impurity 11, identified as Linagliptin impurity YYJ, is a known impurity associated with the antidiabetic agent Linagliptin. This compound serves as a reference standard for the quality control and validation of Linagliptin formulations. Its characterization is crucial for ensuring compliance with regulatory standards and for the assessment of drug purity in pharmaceutical research. -
Drug Impurity
Betamethasone acetate impurity 3 is a known impurity associated with Betamethasone acetate, a corticosteroid used for its anti-inflammatory effects. This compound is essential for assessing the purity and quality of Betamethasone acetate formulations in pharmaceutical research. Its identification and quantification are crucial for regulatory compliance and ensuring the safety and efficacy of steroid-based therapies. -
Drug Impurity
Mirabegron impurity 13 is a known impurity associated with the pharmaceutical compound Mirabegron. As a drug impurity, it is essential for analytical and quality control applications, allowing researchers to assess the purity and stability of Mirabegron formulations. Its identification and quantification contribute to ensuring the safety and efficacy of drug products in compliance with regulatory standards. -
Drug Impurity
Edoxaban Impurity 8 is a chemical impurity associated with the anticoagulant drug Edoxaban. This compound is primarily used for analytical and quality control purposes in pharmaceutical research. Its presence and characterization can provide valuable insights into the stability, purity, and overall quality of Edoxaban formulations. -
Drug Impurity
Progesterone impurity 8, also known as Isoprogesterone, is a drug impurity associated with progesterone synthesis. It may exhibit biological activity and is relevant for studies examining drug metabolism, formulation stability, and impurity profiling in pharmaceutical research. This reagent is valuable for quality control and regulatory compliance in the development of progesterone-based therapies. -
Drug Impurity
Cetirizine Impurity 4 is identified as a chemical impurity associated with the antihistamine Cetirizine. As a relevant research compound, it serves as a standard reference for quality control and method validation in pharmaceutical development. Its characterization is essential for ensuring the safety and efficacy of Cetirizine formulations. Researchers utilize this impurity to investigate the stability and metabolism of Cetirizine in various biological matrices. -
Drug Impurity
Sitagliptin impurity 11 is a known impurity associated with Sitagliptin, a DPP-4 inhibitor used in the treatment of type 2 diabetes. This compound can be utilized in the analysis of drug purity and stability, supporting pharmaceutical researchers in quality control and development of Sitagliptin formulations. Its identification and quantification are essential for ensuring compliance with regulatory standards in drug manufacturing. -
Drug Impurity
Levofloxacin impurity 2, also known as Levofloxacin hydroxy acid, is an impurity associated with the antibiotic Levofloxacin. This compound is of particular interest in the assessment of pharmaceutical quality and safety. It is utilized in research for the characterization of drug impurities and for the evaluation of analytical methods in pharmaceutical development. Its identification and quantification play a critical role in ensuring the integrity and compliance of drug formulations. -
Drug Impurity
Salbutamol impurity 5 is a chemical impurity associated with Salbutamol, a bronchodilator primarily used in the treatment of asthma and other respiratory conditions. This impurity is significant for quality control and regulatory compliance in pharmaceutical development. Its analysis can aid in understanding the stability and safety profiles of Salbutamol formulations, contributing to improved therapeutic efficacy in clinical applications. -
Drug Impurity
Tenofovir impurity 17 is a structural impurity related to the anti-HIV drug tenofovir. Its presence is important for quality control and safety assessments in pharmaceutical formulations. This compound is utilized in research focused on the identification and quantification of impurities, aiding in the overall evaluation of drug purity and compliance with regulatory standards. -
Drug Impurity
Tenofovir impurity 9, also known as Tenofovir disoproxil isopropoxycarbonyl, is a recognized impurity associated with the antiviral drug Tenofovir. This compound is utilized primarily in quality control and analytical research to ensure the purity and safety of Tenofovir formulations. It serves as a valuable reference standard for the identification and quantification of impurities in drug development processes. -
Drug Impurity
Cefmetazole impurity 1 is a known impurity of the cephalosporin antibiotic Cefmetazole, primarily serving as a reference compound for quality control and analytical purposes. Its characterization is essential for understanding the impurity profile of Cefmetazole formulations, ensuring compliance with safety and efficacy standards. This compound aids in the development and validation of analytical methods used in drug testing and quality assurance in pharmaceutical research. -
Drug Impurity
Dacomitinib impurity 12 is a known impurity associated with the drug Dacomitinib, a selective irreversible inhibitor of the EGFR tyrosine kinase. This impurity is relevant for quality control and analytical studies in the pharmaceutical development of Dacomitinib. It is utilized in research to assess the purity and stability of the drug compound in various formulations. -
Drug Impurity
Medroxyprogesterone acetate impurity 3 is a known impurity of the synthetic progestin, Medroxyprogesterone acetate. Its presence is relevant for quality control in pharmaceutical formulations and analytical methods, ensuring the purity and safety of the active pharmaceutical ingredient. This impurity may also be used for research applications aimed at understanding the pharmacological profile and safety assessment of Medroxyprogesterone acetate. -
Drug Impurity
Lopinavir impurity 2 is a known impurity of the antiretroviral drug Lopinavir, primarily characterized by its chemical structure and molecular properties. This reagent is critical for analytical studies focusing on drug purity and stability, particularly in the development and quality control of pharmaceutical formulations. Researchers utilize this impurity to investigate its effects on drug efficacy and safety, enhancing the understanding of Lopinavir's pharmacological profile. -
Drug Impurity
(S)-1-(3-Chloro-4-methylphenyl)ethan-1-amine hydrochloride is characterized as a drug impurity. This compound may arise during the synthesis of certain pharmaceuticals and is important for understanding the purity and safety profiles of drug formulations. Its analysis is critical for compliance with regulatory standards and for ensuring the integrity of drug development processes. -
Montelukast Impurity
Dihydro montelukast is an impurity associated with the synthesis of Montelukast sodium. This compound serves as a useful reference standard for quality control and analytical purposes during the production of Montelukast. Its characterization is essential for ensuring the purity and consistency of Montelukast-containing formulations in research and pharmaceutical applications. -
Drug Impurity
Haloperidol impurity 14 is a known impurity of the antipsychotic agent Haloperidol. This compound is essential for quality control and analytical studies, aiding researchers in assessing purity levels and evaluating potential effects on pharmacological properties. It serves as a critical reference standard in the development and refinement of Haloperidol formulations, ensuring compliance with regulatory standards in pharmaceutical research. -
Drug Impurity
Famotidine impurity 1 is a known impurity associated with the pharmaceutical compound Famotidine, which primarily functions as a histamine H2 receptor antagonist. This reagent is utilized in drug quality assessment and purity analyses to ensure the efficacy and safety of Famotidine formulations. Its presence may impact the pharmacological properties and regulatory compliance of the final drug product, making it essential for research applications focused on drug development and testing. -
Drug Impurity
Rivaroxaban impurity 40 is an identified impurity of the anticoagulant Rivaroxaban, which specifically inhibits Factor Xa. This compound is integral for analytical studies and quality control assessments in pharmaceutical research, aiding in the determination of Rivaroxaban's purity and safety profiles. Its characterization is essential for ensuring compliance with regulatory standards in drug development. -
Drug Impurity
Mycophenolate impurity 3 is a known impurity of the immunosuppressant Mycophenolate. This compound is relevant for the pharmaceutical industry, particularly in the quality control and assessment of drug formulations. Researchers can utilize this impurity to ensure the integrity and compliance of Mycophenolate products in clinical and preclinical studies. -
Drug Impurity
Solifenacin impurity 8 is a chemical impurity associated with Solifenacin, a muscarinic receptor antagonist. This impurity is important for quality control assessments during the synthesis of Solifenacin and can be utilized in the analysis of pharmaceutical formulations to ensure the presence of acceptable impurity levels. Research applications include stability studies and the evaluation of purification methods for the active pharmaceutical ingredient. -
Drug Impurity
Febuxostat impurity 10 is a characterized impurity associated with the drug Febuxostat, a selective inhibitor of xanthine oxidase. This compound is used primarily in pharmaceutical research to assess the purity and stability of Febuxostat formulations. Its identification and analysis can assist in understanding the potential impact of impurities on drug efficacy and safety profiles in drug development processes. -
Drug Impurity
Telmisartan impurity 8 is a chemical impurity associated with Telmisartan, an angiotensin II receptor antagonist used in hypertension management. This impurity is relevant for quality control and analytical characterization in drug development and formulation studies. Researchers can utilize Telmisartan impurity 8 to assess the purity and stability of Telmisartan formulations, contributing to regulatory compliance and pharmacokinetic investigations. -
Drug Impurity
Testosterone impurity 8 is a known impurity of testosterone that can occur during synthesis and formulation processes. This compound serves as an important reference standard in the quality assessment and characterization of testosterone-related products. Its identification and quantification are crucial for ensuring the purity and compliance of pharmaceutical preparations containing testosterone. Researchers can utilize this impurity in stability studies and to investigate potential effects on pharmacological activity. -
Drug Impurity
Amlodipine impurity 4, also known as Phthaloyl Amlodipine, is a recognized drug impurity of Amlodipine. It serves as a valuable reference standard in analytical chemistry and quality control, assisting in the identification and quantification of impurities in pharmaceutical formulations. The characterization of this impurity is critical for ensuring the safety and efficacy of Amlodipine-containing medications. -
Drug Impurity
Azilsartan impurity 17 is an analytical standard used in the quality assessment of Azilsartan formulations. This compound serves as a reference material for regulatory and compliance testing in pharmaceutical development. It is crucial for identifying and quantifying impurities that may arise during drug synthesis, ensuring the safety and efficacy of therapeutic products.
